文献速递临床生化临床免疫

蛋白沉淀与免疫亲和LC-MS/MS定量肺癌标志物CYFRA 21-1

Quantification of the lung cancer tumor marker CYFRA 21-1 using protein precipitation, immunoaffinity bottom-up LC-MS/MS.
PubMed 文献 · Clin Chem Lab Med · 2023-10-30

研究开发并验证了硫酸铵沉淀联合免疫亲和纯化、胰酶消化及LC-MS/MS定量血清CYFRA 21-1的方法,校准曲线在1.0-100 ng/mL范围内线性良好(R2=0.98),准确度和精密度符合接受标准,与常规免疫分析法相关性好。

要点

  • AS沉淀可解决IA纯化中的显著干扰效应。
  • LC-MS/MS法在1.0-100 ng/mL范围内线性良好(R2=0.98)。
  • 疑似肺癌患者血清中与免疫分析法相关性好。

核心结论

  • 成功开发了稳健的AS沉淀-IA LC-MS/MS法用于定量血清CYFRA 21-1。
  • 该方法可进一步探索LC-MS/MS检测相较于免疫分析的临床附加价值。

研究设计与样本

  • 方法学开发与验证研究,采用硫酸铵沉淀、免疫亲和纯化、胰酶消化和LC-MS/MS定量。
  • 使用特征肽段和同位素标记内标进行定量,按EMA指南优化和验证。
  • 结果与常规免疫分析法进行比较。

主要发现

  • IA纯化过程中出现显著干扰效应,通过IA前进行AS沉淀充分解决。
  • 校准曲线在1.0-100 ng/mL范围内线性良好(R2=0.98)。
  • 准确度和精密度均在接受标准内。
  • 在疑似肺癌患者血清中,该方法与免疫分析法显示良好相关性。

关键数值与推荐

  • 校准曲线范围1.0-100 ng/mL,R2=0.98。
  • 准确度和精密度符合接受标准。

临床怎么用

  • 该LC-MS/MS方法可用于血清CYFRA 21-1定量,与免疫分析法相关性好。
  • AS沉淀前处理可解决IA纯化中的干扰问题。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Numerous studies have proven the potential of cytokeratin 19 fragment 21-1 (CYFRA 21-1) detection in the (early) diagnosis and treatment monitoring of non-small cell lung cancer (NSCLC). Conventional immunoassays for CYFRA 21-1 quantification are however prone to interferences and lack diagnostic sensitivity and standardization. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is an emerging approach based on a different, often superior, detection principle, which may improve the clinical applicability of CYFRA 21-1 in cancer diagnostics. Therefore, we developed and validated a protein precipitation, immunoaffinity (IA) LC-MS/MS assay for quantitative analysis of serum CYFRA 21-1. METHODS: Selective sample preparation was performed using ammonium sulfate (AS) precipitation, IA purification, tryptic digestion and LC-MS/MS quantification using a signature peptide and isotopically labeled internal standard. The workflow was optimized and validated according to EMA guidelines and results were compared to a conventional immunoassay. RESULTS: Significant interference effects were seen during IA purification, which were sufficiently solved by performing AS precipitation prior to IA purification. A linear calibration curve was obtained in the range of 1.0-100 ng/mL (R2=0.98). Accuracy and precision were well within acceptance criteria. In sera of patients suspected of lung cancer, the method showed good correlation with the immunoassay. CONCLUSIONS: A robust AS precipitation-IA LC-MS/MS assay for the quantification of serum CYFRA 21-1 was developed. With this assay, the clinically added value of LC-MS/MS-based detection over immunoassays can be further explored.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Genet SAAM, van den Wildenberg SAH, Broeren MAC, et al. Quantification of the lung cancer tumor marker CYFRA 21-1 using protein precipitation, immunoaffinity bottom-up LC-MS/MS. Clin Chem Lab Med. 2023. PMID: 37886827. doi:10.1515/cclm-2023-0795

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。